XML 96 R55.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Of Financial Instruments (Narrative) (Details)
R in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2019
USD ($)
shares
Jun. 30, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2018
ZAR (R)
Jun. 30, 2018
USD ($)
Jun. 30, 2018
ZAR (R)
Derivatives, Fair Value [Line Items]              
Other payables $ 8,801,000 $ 8,801,000 $ 10,814,000        
Transfers into or out of Level 3 $ 0 $ 0          
Foreign Exchange Contracts [Member]              
Derivatives, Fair Value [Line Items]              
Outstanding foreign exchange contracts 0 0 0        
Cell C [Member]              
Derivatives, Fair Value [Line Items]              
Investment amount owned $ 0 $ 0 $ 0        
Adjusted EBITDA       $ 270,900,000     R 3,900.0
EBITDA multiple           6.32% 6.32%
Net external debt       611,400,000     R 8,800.0
Marketability discount           10.00% 10.00%
Equity method investment, percentage of ownership interest 0.00% 0.00%          
DNI [Member]              
Derivatives, Fair Value [Line Items]              
Other payables       26,800,000 R 385.7    
Long-term liabilities           $ 27,200,000 R 373.6
DNI [Member] | Maximum [Member]              
Derivatives, Fair Value [Line Items]              
DNI contingent consideration       $ 27,800,000 R 400.0    
Cell C [Member] | Net1 SA [Member] | Class A [Member]              
Derivatives, Fair Value [Line Items]              
Investment shares owned | shares 75,000,000 75,000,000